Dr Anil Koul said Indians are very efficient in new drug discovery & development, & have best doctors, and change in
Source : Hindustan Times, 26 Oct 2018
Dr. Koul, speaking at the 2nd World Conference on Access to Medical Products, Achieving the SDGs 2030, inaugurated
The Principal Scientific Adviser (PSA) to the Government of India Prof. K. VijayRaghavan addressed members from
for development of newer drugs for drug-resistant infectious diseases
for the prestigious occasion meet on "Antimicrobial Resistance: Need for a United Front". CSIR-IMTech is pleased
There are close to 5,000 preterm births in India every day and close to 25% newborns die due to this
IMTECH has successfully signed a Research Agreement with Kumar Organics Pvt Ltd (KOPL) based out of Bengaluru,
CSIR-IMTech has entered into a new collaboration with global pharmaceutical company, Johnson and Johnson
The BCG vaccine provides immunity to TB only during childhood, this protection lapses as time goes by and the
Natural Streptokinase, Recombinant Streptokinase, Clot-Specific Streptokinase, Anti thrombotic clot
CSIR-Institute of Microbial Technology (CSIR-IMTECH) and Indian Pharmacopoeia Commission signed a Memorandum
List of Novel genera: Albirhodobacter marinus gen. nov 11277 Aquimonas voraii gen. nov., sp. nov.
I. Understanding regulatory mechanisms pertaining to microbial pathogenesis Part A: Understanding the
Rec and PEGylated Staphylokinase (IPR secured) New Immuno-inhibitors and bioactives (leads) Biosensors
Microbial Type Culture Collection and Gene Bank (MTCC) at CSIR-IMTech organizing a workshop on "Advanced
Speaker : Dr. Raushan Kumar Singh, University of Massachusetts Medical School, Worcester
Screen Reader Access
